Sharma S, Chaturvedi A, Dave N, Shah A. Long-term efficacy and safety of RazumabTM (biosimilar ranibizumab) in Indian patients with retinal diseases: results from retrospective REAR RD-2 study. Int J Clin Trials [Internet]. 2022 Oct. 26 [cited 2025 Dec. 25];9(4):255-62. Available from: https://www.ijclinicaltrials.com/index.php/ijct/article/view/641